Neha Agrawal

Neha Agrawal, M.D.

Assistant Professor

Department: Medicine – Jacksonville
Business Phone: (904) 244-8846
Business Email: neha.agrawal@jax.ufl.edu

On This Page

About Neha Agrawal

Neha Agrawal, M.D., is a University of Florida assistant professor of medicine and a gastroenterologist at UF Health Jacksonville. She specializes in hepatology, caring for diseases and disorders of the liver, gallbladder and pancreas. Dr. Agrawal received her medical degree from Motilal Nehru Medical College – Allahabad University in Allahabad, India. She did her internal medicine residency at John H. Stroger Jr. Hospital of Cook County in Chicago, Illinois, and the University of Illinois College of Medicine at Urbana-Champaign in Urbana, Illinois. She completed fellowship training in hepatology at Temple University Hospital in Philadelphia, Pennsylvania.

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine

Clinical Profile

Specialties

  • General Internal Medicine

Subspecialties

  • Hepatology

Areas of Interest

  • Alcoholic Liver Disease
  • Ascites
  • Autoimmune Hepatitis
  • Cirrhosis
  • Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Liver Cancer – Hepatocellular Carcinoma
  • Nonalcoholic Fatty Liver Disease
  • Portacaval Shunting
  • Primary Biliary Cirrhosis
  • Sclerosing Cholangitis
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Research Profile

Areas of Interest

  • Hepatocellular carcinoma
  • Liver Disease
  • Non-alcoholic Fatty Liver Disease

Publications

Academic Articles

Grants

  1. NN9500-7730: Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease

    Active

    Role:
    Principal Investigator
    Funding:
    NOVO NORDISK A/S
  2. A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)

    Active

    Role:
    Principal Investigator
    Funding:
    SYNEOS HEALTH via MADRIGAL PHARMACEUTICALS
  3. Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo controlled trial

    Active

    Role:
    Principal Investigator
    Funding:
    NOVO NORDISK
  4. A Phase 2, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Subjects with Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH)

    Active

    Role:
    Principal Investigator
    Funding:
    GILEAD SCIENCES
  5. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (VANTAGE)

    Active

    Role:
    Principal Investigator
    Funding:
    SYNEOS HEALTH via MIRUM PHARMACEUTICALS

Education

  1. Transplant Hepatology Fellowship

    Temple University Hospital

  2. Internal Medicine Residency

    University of Illinois College of Medicine at Urbana-Champaign

  3. Internal Medicine Residency

    John H. Stroger, Jr. Hospital of Cook County

  4. Bachelor of Medicine, Bachelor of Surgery

    Motilal Nehru Medical College

Contact Details

Phones:
Business:
(904) 244-8846
Emails:
Administrative Manager I:
Addresses:
Business Mailing:
653 W 8TH ST
JACKSONVILLE FL 32209
Business Street:
653 W 8TH ST
JACKSONVILLE FL 32209